Vista Meibo Tears Eye Drops Recalled Nationwide Due to Sterility Concerns
Wizcure Pharmaa Private Limited has voluntarily recalled over 11,000 cartons of Vista Meibo Tears eye drops due to a lack of assurance of sterility and manufacturing violations.
What Happened
Wizcure Pharmaa Private Limited has initiated a voluntary recall of Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops. The recall was prompted by a lack of assurance of sterility, as the products were not manufactured in conformance with current good manufacturing practices (CGMP). This Class II recall was officially classified by the FDA on February 25, 2026.
Which Products Are Affected
The recall affects all lots of the following product:
- Product Name: Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula
- Size: 10 ml (1/3 fl.oz.)
- NDC Number: 77790-003-10
- UPC: 0091241453205
- Quantity: 11,520 cartons
- Recall Number: D-0348-2026
The products were manufactured by Wizcure Pharmaa Private Limited in Bhiwadi, India, and distributed by hi-health, based in Scottsdale, Arizona. The distribution was nationwide across the United States.
What You Should Do
Consumers who have purchased the affected eye drops should stop using the product immediately. The firm initiated the recall via letter notification. Consumers seeking information regarding returns or refunds should contact the distributor, hi-health, at 15207 N. 75th Street, Suite #104, Scottsdale, AZ 85260.
Why This Matters
Ophthalmic products that lack assurance of sterility pose a significant risk to consumers, as contaminated eye drops can lead to serious eye infections, potential vision loss, or other health complications.
Source
Information provided by the FDA.
Source: FDA Official Notice